CMS approves higher reimbursement for VNS epilepsy procedures effective January 2026

LivaNova/VNS Therapy System

CMS elevated VNS Therapy end-of-service procedures to Level 5 APC, increasing provider reimbursement by approximately 48% for new patient implants and 47% for end-of-service procedures at hospital outpatient facilities, effective January 1, 2026.